Data / Form D filings / Thermalin Diabetes, LLC
Thermalin Diabetes, LLC: Form D filings
Thermalin Diabetes, LLC, a biotechnology company in Cleveland, OH, filed 6 Form D notices with the SEC between 2010 and 2014. The latest, on July 28, 2014, reports $6.7 million sold of a $14 million offering to 71 investors.
Find out what Thermalin Diabetes, LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 10000 CEDAR AVENUE, Cleveland, OH, 44106
- Phone
- (617) 695-0523
- Industry
- Biotechnology
- Entity type
- Limited Liability Company
- Incorporated in
- Delaware
- Year incorporated
- 2010
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1502127
The full lists. Form D filings in Ohio: 1,071 rows, $53.55, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 28, 2014 | Amendment | $14,000,000 | $6,654,859 | $7,345,141 | 71 | Jun 26, 2013 | sec.gov |
| Sep 3, 2013 | New notice | $2,525,000 | $2,525,000 | $0 | 33 | May 11, 2012 | sec.gov |
| Jul 10, 2013 | New notice | $10,000,000 | $3,142,094 | $6,857,906 | 28 | Jun 26, 2013 | sec.gov |
| Mar 29, 2011 | Amendment | $3,000,000 | $2,812,759 | $187,241 | 37 | Oct 7, 2010 | sec.gov |
| Feb 24, 2011 | Amendment | $3,000,000 | $2,492,259 | $507,741 | 35 | Oct 7, 2010 | sec.gov |
| Oct 21, 2010 | New notice | $3,000,000 | $1,903,897 | $1,096,103 | 23 | Oct 7, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Richard Berenson | Executive Officer, Director, Promoter | |
| Jeffrey Elton | Director | |
| Raymond Rackley | Director | |
| Gerald Wisler | Director | |
| John Brooks | Director | |
| Bruce H. Frank | Executive Officer | |
| Michael Weiss | Executive Officer, Director, Promoter |
Other biotechnology companies in Ohio that filed recently
- LAACClamp Inc. $900,000 · Oct 5, 2026
- Autology, Inc. $3.4 million · Sep 30, 2026
Every Form D from the week of Jul 28, 2014 · All recent filings in Ohio · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Thermalin Diabetes, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.